Healthtech Startups

Daybreak provides at-home diagnosis and treatment for obstructive sleep apnea through doctor-directed virtual care and custom-tailored therapy. The company serves individuals with sleep apnea, offering an alternative to traditional in-office diagnosis and treatment managed by sleep medicine specialists.

1 investor

The Evidence Company builds an explainable AI (XAI) platform for healthcare that quantifies its own uncertainty, traces decisions to source evidence, and flags unreliable LLM outputs so clinicians know when to trust them. Its products serve healthcare providers and care teams with uses such as AI pre-assessment intake, risk stratification, decision support, and multilingual patient communications.

1 investor

Hale is a personal care platform for men that provides clinician-informed, unbiased product recommendations based on a user's individual needs. It curates and vets grooming and skincare products—covering face, hair, beard, body, fragrance, and dental care—using a medical advisory board and a standardized filtering process.

1 investor

The Health Care Blog is an online publication covering the business of healthcare, health policy, medical practice, and health technology innovations. It reaches a daily audience of healthcare executives, policymakers, physicians, investors, and industry professionals.

1 investor

1 investor

TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.

1 investor

Infraway makes wearable infrared heating pads designed for pain management and recovery. The company serves athletes and individuals managing lower back pain through IoT-enabled heat therapy devices that integrate into daily life.

1 investor

Pogaduszki is a mobile app for speech therapy (logopedic) exercises aimed at children and their parents. The company is transitioning away from its current paid in-app therapy model and preparing a new version of the app.

1 investor

MRN operates a decentralized clinical trial site network that connects trial sponsors with diverse patient populations through flexible, community-based delivery models. The platform provides participating sites with eClinical technology, staffing support, and project management to enable faster patient recruitment and retention across traditional, hybrid, and remote trial settings.

1 investor

The Pack Pet is a direct-to-consumer pet food brand that produces oven-baked dried dog food formulated with prebiotics and probiotics for digestive health. Their products are designed to retain nutrients and flavor through lower-temperature cooking methods compared to industry-standard extrusion.

1 investor

BraceX develops a portable device enabling patients to perform eccentric strengthening exercises safely at home, addressing rehabilitation accessibility barriers for orthopedic injuries and conditions like COPD and Parkinson's Disease.

1 investor

A medtech company developing a platform focused on treating neurological conditions and neurotherapeutics. The company is currently operating in stealth mode.

1 investor

Theraclion develops ultrasound-based medical devices for non-invasive treatment of vascular and thyroid conditions. The company designs robotic platforms combining ultrasound imaging and robotics for patients seeking alternatives to surgery.

1 investor

ActaStim offers an FDA-approved electrical bone growth stimulation device used as an adjunct to lumbar spinal fusion surgery to improve fusion success and reduce failure rates. It is a medical device in the orthopedic/spine care category.

1 investor

Theragraph develops a visualization tool that consolidates patient data into a unified, visual interface to help physicians better manage complex patient information and care. The platform serves healthcare providers seeking to streamline patient care coordination.

1 investor

Therakos develops THERAKOS Photopheresis, an FDA-approved extracorporeal photopheresis (ECP) system used to treat skin symptoms of cutaneous T-cell lymphoma (CTCL) unresponsive to other treatments. It provides medical devices and associated drug therapy for clinicians treating CTCL patients.

1 investor

TheraNova is a venture studio and incubator that develops medical devices from concept through clinical trials, regulation, and commercialization using a shared R&D model. It creates and spins out privately funded medical device companies and has conducted clinical research in the United States, Europe, and South America.

1 investor

A healthcare center in eastern Saxony offering physiotherapy, occupational therapy, speech therapy, podology, and 24-hour intensive care services for patients with complex conditions. The facility combines therapy and care services in a family-oriented environment.

1 investor

Therapy Partners Group operates a network of therapy and behavioral health clinics across the United States, serving patients through a family of clinical practice brands. The company provides support and operational infrastructure for practice owners and therapy professionals managing over 140 clinics in 7 states.

1 investor

Therapydia provides physical therapy services with individualized treatment plans tailored to each patient's needs and recovery goals. It offers direct patient appointments without requiring a referral.

1 investor

Theravance Biopharma develops FDA-approved pharmaceutical treatments, including YUPELRI for chronic obstructive pulmonary disease (COPD) maintenance treatment. The company focuses on delivering innovative medicines that address unmet medical needs.

1 investor

1 investor

Takeda Pharmaceuticals is a global pharmaceutical company developing medicines and creating new standards of care for patients and communities across therapeutic areas.

1 investor

Theriva Biologics is a clinical-stage company developing therapeutics for cancer and related diseases, including an oncolytic adenovirus platform (VCN-01) and enzyme-based candidates for gastrointestinal and systemic conditions (SYN-004, SYN-020). It is a publicly traded biopharmaceutical company (NYSE American: TOVX) focused on areas of high unmet medical need.

1 investor